DE60115263D1 - Verwendung von sulfatiden zur behandlung von diabetes - Google Patents

Verwendung von sulfatiden zur behandlung von diabetes

Info

Publication number
DE60115263D1
DE60115263D1 DE60115263T DE60115263T DE60115263D1 DE 60115263 D1 DE60115263 D1 DE 60115263D1 DE 60115263 T DE60115263 T DE 60115263T DE 60115263 T DE60115263 T DE 60115263T DE 60115263 D1 DE60115263 D1 DE 60115263D1
Authority
DE
Germany
Prior art keywords
isoform
sulfatide
treatment
carbon atoms
sulfatides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115263T
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60115263D1 publication Critical patent/DE60115263D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60115263T 2000-01-27 2001-01-29 Verwendung von sulfatiden zur behandlung von diabetes Expired - Lifetime DE60115263D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000258A SE0000258D0 (sv) 2000-01-27 2000-01-27 Pharmaceutical preparation and method for treatment of diabetes
PCT/SE2001/000169 WO2001054700A1 (en) 2000-01-27 2001-01-29 Pharmaceutical preparation and method for treatment of diabetes

Publications (1)

Publication Number Publication Date
DE60115263D1 true DE60115263D1 (de) 2005-12-29

Family

ID=20278246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115263T Expired - Lifetime DE60115263D1 (de) 2000-01-27 2001-01-29 Verwendung von sulfatiden zur behandlung von diabetes

Country Status (18)

Country Link
US (1) US6908904B2 (de)
EP (1) EP1320372B1 (de)
JP (1) JP2003520818A (de)
KR (1) KR20030005168A (de)
CN (1) CN1396831A (de)
AT (1) ATE310525T1 (de)
AU (1) AU778994B2 (de)
BR (1) BR0107871A (de)
CA (1) CA2398206A1 (de)
CZ (1) CZ20022519A3 (de)
DE (1) DE60115263D1 (de)
HU (1) HUP0203676A3 (de)
MX (1) MXPA02007196A (de)
PL (1) PL356778A1 (de)
RU (1) RU2266123C2 (de)
SE (1) SE0000258D0 (de)
SK (1) SK10762002A3 (de)
WO (1) WO2001054700A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
CA2882553A1 (en) * 2012-08-22 2013-08-22 Regimmune Corporation Preparation for preventing or treating type i diabetes
WO2019238841A1 (en) * 2018-06-15 2019-12-19 Københavns Universitet Coating medical devices to avoid fibroblast overgrowth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
US5302609A (en) * 1992-12-16 1994-04-12 The Regents Of The University Of Michigan Treatment of diabetic nephropathy
SE9601817D0 (sv) * 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
DE69828603T2 (de) 1997-04-10 2005-12-29 Kirin Beer K.K. Verwendung von a-Glycosylceramiden zur Herstellung eines therapeutischen Mittels zur Behandlung von Autoimmunkrankheiten
EP1049477A1 (de) * 1997-12-30 2000-11-08 A+ Science Invest AB Galactosylceramide, glucosylceramide, lactosylceramide, und spezifische fänger für diese zur verwendung in der prophylaxe oder therapie der prädiabetes, diabetes und/oder damit zusammenhängender komplikationen
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes

Also Published As

Publication number Publication date
PL356778A1 (en) 2004-07-12
JP2003520818A (ja) 2003-07-08
KR20030005168A (ko) 2003-01-17
HUP0203676A3 (en) 2003-08-28
RU2266123C2 (ru) 2005-12-20
CN1396831A (zh) 2003-02-12
HUP0203676A2 (hu) 2003-04-28
EP1320372A1 (de) 2003-06-25
CA2398206A1 (en) 2001-08-02
WO2001054700A1 (en) 2001-08-02
SK10762002A3 (sk) 2003-07-01
AU3069101A (en) 2001-08-07
EP1320372B1 (de) 2005-11-23
AU778994B2 (en) 2004-12-23
BR0107871A (pt) 2002-11-05
CZ20022519A3 (cs) 2003-06-18
SE0000258D0 (sv) 2000-01-27
ATE310525T1 (de) 2005-12-15
RU2002122982A (ru) 2004-03-20
US20030004115A1 (en) 2003-01-02
MXPA02007196A (es) 2003-01-28
US6908904B2 (en) 2005-06-21

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE481970T1 (de) Zusammensetzungen enthaltend capsaicin oder capsaicin analoge und ein anästhetikum
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
Sanderson et al. Lipids and Dupuytren's disease
KR900700089A (ko) 전신성 피부 투과적 투여를 위한 약학적 조성물
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
BR9911112A (pt) Petpìdeo-1 semelhante a glucagon aperfeiçoa aresposta de ß-células à glicose em pacientes comtolerância à glicose prejudicada
SE9804064D0 (sv) Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DE59508360D1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
DE69932414D1 (de) Indole-3-propionsäure, ihre salze und ester als arzneimittel
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
Cameron et al. Microvascular alterations in chronically streptozotocin-diabetic rats
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
DK0764632T3 (da) Selektive beta3-adrenerge agonister
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
DE60115263D1 (de) Verwendung von sulfatiden zur behandlung von diabetes
WO1997022354A3 (de) Anwendung eines medikaments und verwendung eines stoffgemischs zur herstellung eines medikaments
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
EA200300436A1 (ru) Производные триптамина и аналогичные соединения и содержащие их фармацевтические композиции
ATE249832T1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
HK1042238A1 (en) Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
DE60120371D1 (de) Verwendung von wachstumshormon in niederen dosen
RO117893B1 (ro) Metodă de anestezie generală, la cabaline

Legal Events

Date Code Title Description
8332 No legal effect for de